Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Acasunlimab by BioNTech for Endometrial Cancer: Likelihood of Approval
Acasunlimab is under clinical development by BioNTech and currently in Phase II for Endometrial Cancer. According to GlobalData, Phase II...